Jun 292026 Programming biology: next-gen AI firms raise billions to design better medicines Here’s a useful article covering industry developments in the AI x Bio space. Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain.
